Mangoceuticals Inc (MGRX) USD0.0001

Sell:$4.05Buy:$4.19$0.24 (5.52%)

Prices delayed by at least 15 minutes
Sell:$4.05
Buy:$4.19
Change:$0.24 (5.52%)
Prices delayed by at least 15 minutes
Sell:$4.05
Buy:$4.19
Change:$0.24 (5.52%)
Prices delayed by at least 15 minutes

Company Information

About this company

Mangoceuticals, Inc. is primarily focused on developing, marketing, and selling a variety of men’s health and wellness products and services via a secure telemedicine platform. The Company has developed and is commercially marketing a new brand of erectile dysfunction (ED) products under the brand name Mango and a brand of hair loss products under the brand name Grow. These products are produced at a compounding pharmacy using a proprietary combination of United States Food and Drug Administration (FDA) approved ingredients and are available to patients on the determination of a prescribing physician that the compounded drug is necessary for the individual patient. It is marketing and selling these branded ED and hair loss products exclusively online via its Website at www.MangoRx.com. Its customer platform connects consumers to licensed healthcare professionals through its Website for the provision of care via telehealth. It also owns a global patent portfolio of oral solution.

Key people

Jacob D. Cohen
Chairman of the Board, Chief Executive Officer
Antonios Isaac
President, Director
Eugene M. Johnston
Chief Financial Officer
Amanda Hammer
Chief Operating Officer
Lorraine Dalessio
Independent Director
Alex P. Hamilton
Independent Director
Kenny Myers
Independent Director
Click to see more

Key facts

  • EPIC
    MGRX
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Healthcare Facilities
  • ISIN
    US56270V2051
  • Market cap
    $20.82m
  • Employees
    -
  • Shares in issue
    4.97m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.